GE Healthcare is the famous Corporate Investor, which was founded in 1892. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Fairfield.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the GE Healthcare, startups are often financed by Elbit Imaging Ltd., Clarus Ventures, Boston MedTech Advisors. The meaningful sponsors for the fund in investment in the same round are York Capital Management, GEOC, Elbit Imaging Ltd.. In the next rounds fund is usually obtained by York Capital Management, GEOC, Elbit Imaging Ltd..
We also calculated 14 valuable employees in our database.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Check-Cap, CASI Pharmaceuticals, SpinalMotion.
The higher amount of exits for fund were in 2015. Opposing the other organizations, this GE Healthcare works on 4 percentage points more the average amount of lead investments. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year. The average startup value when the investment from GE Healthcare is 100-500 millions dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this Corporate Investor is 36 percentage points more often commits exit comparing to other companies.
Related Funds
| Fund Name | Location |
| Brustart | Belgium, Brussels-Capital, City of Brussels |
| Dutco Group | Deira, Dubai, United Arab Emirates |
| Frameworks | Japan, Tokyo |
| HB4 | Emilia-Romagna, Italy, Modena |
| Jinwin Investment | China, Shanghai |
| NextSteps Capital | - |
| Shenzhenshi Licheng Zhihe Chuangtou | China, Guangdong, Tianjin |
| The Group Investment | - |
| Toggenburger | Switzerland, Winterthur, Zurich |
| VAM Investments | Canton Esch-sur-Alzette, Esch-sur-Alzette, Luxembourg |
Adam Colclough Senior Portfolio Manager 63954759780cbb534f4137c334e5 51da2ec5ab6812268 fc7d834536e3efa 5c12c5941524ac7d5fc58181685e3d9f 4a6eb36179946ce e4ee2afbd06e20ace02e22cb7dd09198 12a52403495a0d 230168b5d60ed4ed0eb7aaf2c80fd652 cc530327c935ef 8e77588e7da5695dab01b16e 
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Nucleus RadioPharma | 05 Jun 2024 | Rochester, New York, United States | |||
Laza Medical | $36M | 12 Dec 2023 | - | ||
Nucleus RadioPharma | $56M | 17 Oct 2023 | Rochester, New York, United States | ||
Centerline Biomedical | $33M | 27 Jun 2022 | Cleveland, Ohio, United States | ||
OhMD | $4M | 22 Feb 2022 | Burlington, Vermont, United States | ||
Decisio Health | $15M | 04 Dec 2019 | Houston, Texas, United States | ||
Adavium | $21M | 07 Apr 2016 | Palo Alto, California, United States | ||
InSightec | $30M | 11 Dec 2012 | North District | ||
C8 MediSensors | $19M | 12 Jun 2012 | San Jose, California, United States |
– CMR Surgical is a Cambridge UK-based surgical robotic company.
– Series D $600M round was led by SoftBank Vision Fund 2 with participation from Ally Bridge Group, new investors RPMI Railpen, Tencent and Chimera, and existing investors LGT and its affiliate impact investing platform Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences and GE Healthcare.
– The investment will be used for the global commercialization of Versius and further develop the company’s digital ecosystem.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Nucleus RadioPharma | 05 Jun 2024 | Rochester, New York, United States | |||
Laza Medical | $36M | 12 Dec 2023 | - | ||
Nucleus RadioPharma | $56M | 17 Oct 2023 | Rochester, New York, United States | ||
Centerline Biomedical | $33M | 27 Jun 2022 | Cleveland, Ohio, United States | ||
OhMD | $4M | 22 Feb 2022 | Burlington, Vermont, United States | ||
Decisio Health | $15M | 04 Dec 2019 | Houston, Texas, United States | ||
Adavium | $21M | 07 Apr 2016 | Palo Alto, California, United States | ||
InSightec | $30M | 11 Dec 2012 | North District | ||
C8 MediSensors | $19M | 12 Jun 2012 | San Jose, California, United States |
